Myovant Sciences Ltd (NYSE:MYOV)
| 14.42 Delayed Data As of 4:00pm ET |  -0.31 / -2.10%Today’s Change | 13.14 Today|||52-Week Range 27.43 | -7.39% Year-to-Date |
Latest MYOV News | Press Releases
No recent news for Myovant Sciences Ltd.
Today’s Trading
| Previous close | 14.73 |
| Today’s open | 14.49 |
| Day’s range | 14.33 - 15.33 |
| Volume | 987,283 |
| Average volume (3 months) | 674,249 |
| Market cap | $1.4B |
Data as of 4:00pm ET, 01/19/2022
Growth & Valuation
| Earnings growth (last year) | +15.83% |
| Earnings growth (this year) | +28.74% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 31.24 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BCYCBicycle Therapeutics... | +0.11 | +0.24% |
| EDITEditas Medicine Inc | +0.03 | +0.15% |
| ATRAAtara Biotherapeutic... | +0.34 | +2.28% |
| ALECAlector Inc | +0.15 | +0.94% |
Data as of 4:00pm ET, 01/19/2022
Financials
| Next reporting date | January 26, 2022 |
| EPS forecast (this quarter) | -$0.61 |
| Annual revenue (last year) | $59.3M |
| Annual profit (last year) | -$255.1M |
| Net profit margin | -430.12% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters London, Greater London |
Forecasts
